<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" width="783px" height="3441px" viewBox="-0.5 -0.5 783 3441" content="&lt;mxfile host=&quot;app.diagrams.net&quot; modified=&quot;2020-06-25T22:38:39.822Z&quot; agent=&quot;5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.116 Safari/537.36&quot; etag=&quot;vapKCN_oZ52IY3SNobd3&quot; version=&quot;13.3.4&quot; type=&quot;github&quot;&gt;&lt;diagram id=&quot;8JQaeR7ikDl0GVS66GYh&quot; name=&quot;Page-1&quot;&gt;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&lt;/diagram&gt;&lt;/mxfile&gt;" resource="https://app.diagrams.net/?title=Copy%20of%20modele.svg&amp;client=1#HMedeler%2Fhtml%2Fmaster%2Fpdf%2Fsvg%2F155_tuberculose.svg"><defs/><g><rect x="20" y="1910" width="760" height="310" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="2744" width="760" height="696" fill="none" stroke="#000000" pointer-events="all"/><rect x="430" y="2760" width="350" height="120" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 343px; height: 1px; padding-top: 2767px; margin-left: 437px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le <b>suivi </b>comprend :</div><div><ul><li>clinique, RXT, bactério jusqu'à négativation</li><li>vision couleurs mensuel pendant ttt EMB</li><li>bilan hépatique</li><ul><li>arrêt PZA si &gt; 3N</li><li>arrêt PZA et INH si &gt; 6N</li></ul></ul></div></div></div></div></foreignObject><text x="437" y="2779" fill="#000000" font-family="Karla" font-size="12px">Le suivi comprend :...</text></switch></g><rect x="100" y="2760" width="330" height="110" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 323px; height: 1px; padding-top: 2767px; margin-left: 107px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le bilan <b>pré-thérapeutique</b> comprend :</div><ul><li>NFS, Na<sup>+</sup>, créat, bilan hépato-rénal, uricémie</li><li>séro VIH, VHB, VHC</li><li>examen ophtalmo + vision couleurs (rifampicine)</li><li>recherche grossesse (pyrazinamide)</li></ul></div></div></div></foreignObject><text x="107" y="2779" fill="#000000" font-family="Karla" font-size="12px">Le bilan pré-thérapeutique comprend :...</text></switch></g><rect x="22" y="1210" width="760" height="640" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="120" width="760" height="840" fill="none" stroke="#000000" pointer-events="all"/><rect x="0" y="100" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 115px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Généralités</div></div></div></foreignObject><text x="40" y="119" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Généralités</text></switch></g><rect x="90" y="140" width="690" height="160" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 132px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>maladie transmissible liée à <b>Mycobacterium tuberculosis</b> (= BK), parfois M. bovis ou M. africanum<br /></li><li>BAAR aérobie à croissance lente et à multiplication intra- et extra-cellulaire</li><li>localisation principalement <b>pulmonaire </b>(mais peut concerner n'importe quel organe)</li><li>France </li><ul><li>faible incidence : 7/100 000/an</li><li>surtout IDF, Mayotte, Guyane, migrants d'Afrique subsaharienne, SDF</li></ul><li>monde</li><ul><li>10M cas/an avec 1.5M décès/an</li><li>F5 décès par maladie, F2 décès par maladie infectieuse<br /></li><li>6% sont des tuberculoses multi-résistantes (surtout ex-URSS, Chine, Inde)</li></ul></ul></div></div></div></foreignObject><text x="72" y="144" fill="black" font-family="Karla" font-size="12px">maladie transmissible liée à Mycobacterium tuberculosis (= BK), parfois M. bovis ou M. africanum...</text></switch></g><rect x="20" y="140" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 150px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">généralités</div></div></div></foreignObject><text x="55" y="154" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">généralités</text></switch></g><rect x="90" y="300" width="690" height="220" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 292px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ol><li style="font-size: 12px"><b>Contamination </b>: inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= <b style="font-size: 12px">foyer primaire</b>)</li><li style="font-size: 12px"><span style="font-size: 12px"><b>Primo-infection</b> (= PIT) souvent asymptomatique (= ITL = infection tuberculeuse latente)</span></li><ul style="font-size: 12px"><li style="font-size: 12px">BK phagocytés puis multipliés dans <b style="font-size: 12px">macrophages </b>alvéolaires puis gagnent le gg hilaire. Le <b>complexe primaire</b> <br style="font-size: 12px" />est l'association foyer primaire + adénopathie, pouvant rester visible en RXT pendant des années</li><li style="font-size: 12px">Dans les semaines qui suivent la PIT : <b>réponse immune</b> pour limiter la multiplication de BK. L'afflux des monocytes épithélioïdes forme les granulomes giganto-cellulaires avec nécrose caséeuse contenant des bacilles quiescents. </li><li style="font-size: 12px">L'ITL est parfois patente avec AEG, érythème noueux, kérato-conjonctivite phlycténulaire, adn cervicales. </li></ul><li><span style="font-size: 12px"><b>Tuberculose maladie</b> (= TM) : multiplication des BK (pendant ou après ITL)</span></li><ul><li><span style="font-size: 12px">5% des tuberculeux font une TM &lt; 2 ans post-PIT, 5% font une TM &gt; 2 ans post-PIT</span></li><li>développement d'une TM favorisé par :</li><ul><li>imD, diabète, InRé</li><li>fragilité : imD, âges extrêmes, malnutrition, précarité</li><li>alcool, tabac, toxicomanie</li></ul></ul></ol></div></div></div></foreignObject><text x="72" y="304" fill="#000000" font-family="Karla" font-size="12px">Contamination : inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= foyer primaire)Primo-infection...</text></switch></g><rect x="20" y="300" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 315px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">histoire naturelle</div></div></div></foreignObject><text x="55" y="319" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">histoire na...</text></switch></g><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" transform="translate(2,3)" opacity="0.25"/><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 598px; height: 1px; padding-top: 40px; margin-left: 101px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font style="font-size: 30px">155 - Tuberculose</font></div></div></div></foreignObject><text x="400" y="44" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">155 - Tuberculose</text></switch></g><rect x="92" y="1230" width="690" height="70" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1222px; margin-left: 79px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>signes cliniques évoluant depuis des semaines ou des mois</li><li>RXT : nodules, infiltrats ou cavités des lobes supérieurs et postérieurs</li><li>contexte évocateur : contage, voyage, CSP, imD</li></ul></div></div></div></foreignObject><text x="79" y="1234" fill="black" font-family="Karla" font-size="12px">signes cliniques évoluant depuis des semaines ou des moisRXT : nodules, infiltrats ou cavités des lobes supérieurs et...</text></switch></g><rect x="22" y="1230" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1240px; margin-left: 23px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">suspicion</div></div></div></foreignObject><text x="57" y="1244" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">suspicion</text></switch></g><rect x="22" y="1300" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1315px; margin-left: 23px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">diagnostic<br />positif</div></div></div></foreignObject><text x="57" y="1319" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">diagnostic...</text></switch></g><rect x="92" y="1300" width="690" height="390" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1307px; margin-left: 99px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font>3 prélèvements en 24h :<br /><ul><li><font>ECBC en mycobactériologie (recherche de BAAR)</font></li><ul><li><font>si le patient ne crache pas, tubage gastrique le matin à jeun avant le lever</font></li></ul><li>si échec (3 prélèvements négatifs)</li><ul><li>fibroscopie bronchique avec aspiration dirigée <b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li></ul><li><span style="font-size: 12px">si miliaire</span></li><ul><li><span style="font-size: 12px">fibroscopie bronchique avec aspiration dirigée </span><b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li><li><font color="#202122"><span style="font-size: 12px">hémoc sur milieu isolator</span></font></li><li><font color="#202122"><span style="font-size: 12px">ECBU en mycobactériologie</span></font></li><li><font color="#202122"><span style="font-size: 12px">si leuco-neutropénie : myéloculture</span></font></li></ul><li><span style="color: rgb(32 , 33 , 34)">si extra-pulmonaire :</span><br /></li><ul><li><span style="color: rgb(32 , 33 , 34)">ganglionnaire : ponction ou biopsie-exérèse d'adénopathie accessible</span></li><li><span style="color: rgb(32 , 33 , 34)">neuro-méningée : PL</span></li><li><span style="color: rgb(32 , 33 , 34)">génito-urinaire : ECBU 3 jours de suite</span></li></ul></ul><div>3 <b>populations </b>de BK sont à cibler :<br /><ul><li>extra-cellulaires (95%)</li><ul><li>responsables de la contagiosité et symptômes</li><li>ssb à : INH, RMP et streptomycine</li></ul><li>intra-cellulaires quiescents<br /></li><ul><li>ssb à : PZA et RMP</li></ul><li>extra-cellulaires dans le caséeum<br /></li><ul><li>responsables de la rechute à distance</li><li>ssb à : RMP</li></ul></ul></div></font></div></div></div></foreignObject><text x="99" y="1319" fill="#000000" font-family="Karla" font-size="12px">3 prélèvements en 24h :...</text></switch></g><rect x="22" y="1690" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1700px; margin-left: 23px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">analyse</div></div></div></foreignObject><text x="57" y="1704" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">analyse</text></switch></g><rect x="92" y="1690" width="690" height="150" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1682px; margin-left: 79px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures. Coloration positive ssi &gt; 10<sup>3</sup><span> bacilles/mL. Répéter les prélèvements si examen direct négatif (n'élimine pas le diagnostic)</span></li><li><span>anapath : granulomes épithélioïdes gigantocellulaires avec nécrose caséeuse (très évocateur mais non pathognomonique de la tuberculose)</span></li><li>culture sur milieux enrichis</li><ul><li>milieu solide (Löwenstein-Jensen) en 3-4 semaines</li><li>milieu liquide en 10-15 jours mais doit être reconfirmé par examen direct</li></ul><li><span style="font-size: 12px">identification (M. tuberculosis ou atypique) par biochimie, culture ou PCR</span></li><li>ATBg obligatoire (résistance rifampicine ou INH)</li></ul></div></div></div></foreignObject><text x="79" y="1694" fill="black" font-family="Karla" font-size="12px">examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures. Coloration positive ssi &gt; 103 bacilles/mL. Ré...</text></switch></g><rect x="2" y="1190" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 1205px; margin-left: 3px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Diagnostic</div></div></div></foreignObject><text x="42" y="1209" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Diagnostic</text></switch></g><rect x="20" y="520" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 535px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">formes<br />pulmonaires</div></div></div></foreignObject><text x="60" y="539" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">formes...</text></switch></g><rect x="100" y="520" width="680" height="350" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 527px; margin-left: 107px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les formes <b>pulmonaires </b>représentent <b>75%</b> des cas<br /><ul><li><b>Tuberculose pulmonaire commune</b> (la plus classique)</li><ul><li>pas de st spécifique : signes généraux, respiratoires (voire pleural)</li><li>lésions des segments postérieurs des lobes supérieurs (PO2 plus élevée : BK aérobie strict)</li><li>3 types de lésions pouvant s'associer : nodules, infiltrats et cavernes</li></ul><li><span style="font-size: 12px"><b>Miliaire </b>tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme disséminée, généralisée, évolution svt défavorable : doit être pec rapidement</span></li><li><span style="font-size: 12px">PID micronodulaire en "grains de mil" bilatérale (parfois lésions macro-nodulaires si forme évoluée)</span></li></ul><li><span style="font-size: 12px"><b>Pleurésie </b>tuberculeuse</span></li><ul><li>épanchement exsudatif et lymphocytaire, unilatéral</li><li>examen direct positif dans &lt; 10%, culture (liquide ou biopsie) positive dans &lt; 30%, anapath de biopsies pleurales positives dans &gt; 80%</li></ul><li><span style="font-size: 12px"><b>Pneumonie aigüe</b> tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme aigüe rare : ensemencement massif de BK sur lésion excavée avec inflammation intense</span></li><li><span style="font-size: 12px">RXT : comme PAC avec petites excavations</span></li></ul></ul><div>Les formes <b>extra-pulmonaires</b> représentent <b>25%</b> des cas, peuvent toucher tous les organes, mais surtout :</div><div><ul><li>gg (50% des formes extra-pulmonaires) : surtout cervicale et médiastinale</li><li>ostéo-articulaire : surtout spondylodiscite tuberculeuse (= mal de Pott)</li><li>génito-urinaire</li><li>neuro-méningée</li></ul></div></div></div></div></foreignObject><text x="107" y="539" fill="#000000" font-family="Karla" font-size="12px">Les formes pulmonaires représentent 75% des cas...</text></switch></g><rect x="20" y="870" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 885px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">séquelles<br />pulmonaires</div></div></div></foreignObject><text x="60" y="889" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">séquelles...</text></switch></g><rect x="100" y="870" width="680" height="80" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 693px; height: 1px; padding-top: 862px; margin-left: 87px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>lésions fibreuses rétractiles</li><li>DDB (haut risque d'hémoptysie car hypervascularisation)</li><li>aspergillome (risque d'hémoptysie par lésion d'une branche de l'artère pulmonaire)</li><li>séquelles de PIT : chancre d'inoculation calcifié</li></ul></div></div></div></foreignObject><text x="87" y="874" fill="#000000" font-family="Karla" font-size="12px">lésions fibreuses rétractilesDDB (haut risque d'hémoptysie car hypervascularisation)aspergillome (risque d'hémoptysi...</text></switch></g><rect x="20" y="2760" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 2775px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">bilans</div></div></div></foreignObject><text x="60" y="2779" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">bilans</text></switch></g><rect x="20" y="3228" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 3243px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">traitement</div></div></div></foreignObject><text x="55" y="3247" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">traitement</text></switch></g><rect x="90" y="3228" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 3235px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">En général 6 mois : <b>quadrithérapie 2 mois</b> puis <b>bithérapie 4 mois<br /></b></div></div></div></foreignObject><text x="97" y="3247" fill="#000000" font-family="Karla" font-size="12px">En général 6 mois : quadrithérapie 2 mois puis bithérapie 4 mois&#xa;</text></switch></g><rect x="20" y="2910" width="90" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 88px; height: 1px; padding-top: 2920px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">médicaments</div></div></div></foreignObject><text x="65" y="2924" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">médicaments</text></switch></g><rect x="0" y="2720" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 2735px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">TM</div></div></div></foreignObject><text x="30" y="2739" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">TM</text></switch></g><path d="M 220 3258 L 217.5 3258 Q 215 3258 215 3268 L 215 3275.5 Q 215 3283 212.5 3283 L 211.25 3283 Q 210 3283 212.5 3283 L 213.75 3283 Q 215 3283 215 3293 L 215 3300.5 Q 215 3308 217.5 3308 L 220 3308" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 270 3258 L 267.5 3258 Q 265 3258 265 3268 L 265 3275.5 Q 265 3283 262.5 3283 L 261.25 3283 Q 260 3283 262.5 3283 L 263.75 3283 Q 265 3283 265 3293 L 265 3300.5 Q 265 3308 267.5 3308 L 270 3308" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,265,3283)" pointer-events="all"/><rect x="220" y="3258" width="40" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3283px; margin-left: 221px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />PZA<br />EMB</div></div></div></foreignObject><text x="240" y="3287" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><rect x="363" y="3258" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3273px; margin-left: 364px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="383" y="3277" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 413 3258 L 410.5 3258 Q 408 3258 408 3265.5 L 408 3269.25 Q 408 3273 405.5 3273 L 404.25 3273 Q 403 3273 405.5 3273 L 406.75 3273 Q 408 3273 408 3280.5 L 408 3284.25 Q 408 3288 410.5 3288 L 413 3288" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,408,3273)" pointer-events="all"/><path d="M 363 3258 L 360.5 3258 Q 358 3258 358 3265.5 L 358 3269.25 Q 358 3273 355.5 3273 L 354.25 3273 Q 353 3273 355.5 3273 L 356.75 3273 Q 358 3273 358 3280.5 L 358 3284.25 Q 358 3288 360.5 3288 L 363 3288" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="90" y="3338" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 3345px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Si CI PZA : <b>trithérapie 3 mois </b>puis <b>bithérapie 6 mois</b></div></div></div></foreignObject><text x="97" y="3357" fill="#000000" font-family="Karla" font-size="12px">Si CI PZA : trithérapie 3 mois puis bithérapie 6 mois</text></switch></g><rect x="160" y="3368" width="40" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3388px; margin-left: 161px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />EMB</div></div></div></foreignObject><text x="180" y="3392" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 160 3368 L 157.5 3368 Q 155 3368 155 3378 L 155 3383 Q 155 3388 152.5 3388 L 151.25 3388 Q 150 3388 152.5 3388 L 153.75 3388 Q 155 3388 155 3398 L 155 3403 Q 155 3408 157.5 3408 L 160 3408" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 210 3368 L 207.5 3368 Q 205 3368 205 3378 L 205 3383 Q 205 3388 202.5 3388 L 201.25 3388 Q 200 3388 202.5 3388 L 203.75 3388 Q 205 3388 205 3398 L 205 3403 Q 205 3408 207.5 3408 L 210 3408" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,205,3388)" pointer-events="all"/><rect x="290" y="3368" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3383px; margin-left: 291px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="310" y="3387" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 290 3368 L 287.5 3368 Q 285 3368 285 3375.5 L 285 3379.25 Q 285 3383 282.5 3383 L 281.25 3383 Q 280 3383 282.5 3383 L 283.75 3383 Q 285 3383 285 3390.5 L 285 3394.25 Q 285 3398 287.5 3398 L 290 3398" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 340 3368 L 337.5 3368 Q 335 3368 335 3375.5 L 335 3379.25 Q 335 3383 332.5 3383 L 331.25 3383 Q 330 3383 332.5 3383 L 333.75 3383 Q 335 3383 335 3390.5 L 335 3394.25 Q 335 3398 337.5 3398 L 340 3398" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,335,3383)" pointer-events="all"/><path d="M 650 3348 L 650 3347.83 L 660 3347.84 L 670 3348.5 L 680 3347.67 L 690 3348.03 L 700 3348.44 L 710 3347.68 L 720 3348.08 L 730 3347.51 L 740 3348.41 L 750 3347.47 L 760 3348 L 759.97 3348 L 760.07 3356 L 759.91 3364 L 759.91 3372 L 760.07 3380 L 760 3388 L 760 3387.75 L 750 3387.5 L 740 3388.42 L 730 3387.92 L 720 3388.38 L 710 3387.46 L 700 3388.33 L 690 3387.96 L 680 3388.37 L 670 3388.35 L 660 3387.6 L 650 3388 L 649.86 3388 L 649.99 3380 L 650.14 3372 L 650.01 3364 L 650.05 3356 L 650 3348 L 650 3348 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 3368px; margin-left: 651px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les ATB sont à adapter selon l'ATBg</div></div></div></foreignObject><text x="705" y="3372" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">Les ATB sont à ada...</text></switch></g><rect x="110" y="2910" width="670" height="290" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 663px; height: 1px; padding-top: 2917px; margin-left: 117px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Les anti-tuberculeux utilisés en <b>1e intention</b> sont :</div><ul><li><b>Isoniazide </b>= INH (RIMIFON)</li><ul><li>EI : <b>hépatite</b>, nausées, polynévrite sst-mot si carence B6, rarement tb neuro-psy, réactions cutanées ou algodystrophies (sd épaule-main)</li></ul><li><b>Rifampicine </b><span>= RMP (RIMACTAN, RIFADINE)</span><br /></li><ul><li><span>EI : </span><b>coloration en orange</b><span> des larmes, sperme et urines (normal), nausées, phénomènes immuno-allergiques (thrombopénie, hémolyse, InRéA)</span><br /></li><li>intéractions : anticoagulants oraux, pilule oestro-progestative (changer), inhibiteurs de protéase, CTC, digitaliques, peut augmenter l'hépatotoxicité de INH et PZA</li></ul><li><span style="font-size: 12px"><b>Pyrazinamine </b>= PZA (PIRILENE)</span></li><ul><li><span style="font-size: 12px">CI si InHep ou InRé</span></li><li><span style="font-size: 12px">EI : cytolise hépatique (plus tardif que INH), hyperuricémie svt ast, rash vasomoteur, nausées</span></li></ul><li><span style="font-size: 12px"><b>Ethambutol</b> = EMB (MYAMBUTOL, DEXAMBUTOL)</span></li><ul><li><span style="font-size: 12px">EI : névrite optique rétrobulbaire (fris : posologie élevée, éthylisme chronique, InRé) nécessitant une cs ophtalmo tous les mois pendant le traitement</span></li></ul></ul><div>En <b>2e intention</b>, on peut utiliser des <b>aminosides </b>(streptomycine et amikacine). Les EI principaux sont les toxicités rénale et auditive. Les <b>FQ </b>sont aussi utilisables en 2e intention</div></div></div></div></foreignObject><text x="117" y="2929" fill="black" font-family="Karla" font-size="12px">Les anti-tuberculeux utilisés en 1e intention sont :...</text></switch></g><path d="M 430 2880 L 430 2760" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 650 3228 L 650 3227.36 L 660 3228.26 L 670 3227.86 L 680 3228.29 L 690 3228.43 L 700 3227.71 L 710 3227.65 L 720 3227.99 L 730 3227.3 L 740 3228.26 L 750 3227.64 L 760 3228 L 759.73 3228 L 760.44 3238 L 759.65 3248 L 760.48 3258 L 759.77 3268 L 760 3278 L 760 3278.67 L 750 3278.28 L 740 3278.04 L 730 3277.91 L 720 3277.94 L 710 3277.84 L 700 3278.18 L 690 3277.37 L 680 3277.35 L 670 3278.25 L 660 3278.38 L 650 3278 L 650.31 3278 L 649.25 3268 L 650.02 3258 L 649.32 3248 L 649.33 3238 L 650 3228 L 650 3228 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 3253px; margin-left: 651px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si neuro-méningée : durée de 9-12 mois</div></div></div></foreignObject><text x="705" y="3257" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si neuro-méningée...</text></switch></g><path d="M 640 3288 L 640 3287.5 L 650 3288.65 L 660 3288.02 L 670 3287.83 L 680 3288.47 L 690 3288.73 L 700 3287.98 L 710 3287.71 L 720 3288.47 L 730 3288.36 L 740 3288.52 L 750 3288.66 L 760 3288 L 760.54 3288 L 759.37 3298 L 760.02 3308 L 760.35 3318 L 759.46 3328 L 760 3338 L 760 3338.13 L 750 3338.44 L 740 3338.06 L 730 3338.05 L 720 3337.25 L 710 3337.78 L 700 3337.4 L 690 3337.79 L 680 3338.23 L 670 3338.7 L 660 3337.57 L 650 3337.68 L 640 3338 L 639.3 3338 L 639.77 3328 L 639.32 3318 L 640.74 3308 L 640.25 3298 L 640 3288 L 640 3288 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 118px; height: 1px; padding-top: 3313px; margin-left: 641px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si miliaire très sévère : ajout CTC</div></div></div></foreignObject><text x="700" y="3317" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si miliaire très sév...</text></switch></g><path d="M 572 1380 L 572 1380.67 L 582 1380.46 L 592 1380.66 L 602 1379.98 L 612 1380.22 L 622 1380.01 L 632 1380.04 L 642 1380.19 L 652 1379.93 L 662 1379.48 L 672 1379.46 L 682 1380.65 L 692 1379.74 L 702 1379.91 L 712 1379.42 L 722 1379.89 L 732 1380.58 L 742 1379.26 L 752 1380.37 L 762 1380 L 762.35 1380 L 762.37 1390 L 761.43 1400 L 762.45 1410 L 761.9 1420 L 761.48 1430 L 762.61 1440 L 762 1450 L 762 1450.45 L 752 1450.29 L 742 1450.59 L 732 1449.87 L 722 1449.67 L 712 1449.65 L 702 1450.16 L 692 1450.19 L 682 1449.88 L 672 1450.03 L 662 1450.13 L 652 1449.74 L 642 1450.49 L 632 1449.69 L 622 1450.41 L 612 1449.97 L 602 1450.23 L 592 1449.79 L 582 1449.61 L 572 1450 L 571.6 1450 L 572.7 1440 L 572.35 1430 L 572.27 1420 L 571.64 1410 L 572.64 1400 L 572.53 1390 L 572 1380 L 572 1380 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 188px; height: 1px; padding-top: 1415px; margin-left: 573px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Dès la suspicion de tuberculose, il faut <b>isoler </b>le patient. L'isolement peut être levé après 15 jours de ttt. </div></div></div></foreignObject><text x="667" y="1419" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">Dès la suspicion de tuberculose...</text></switch></g><path d="M 662 1230 L 662 1230.31 L 672 1229.38 L 682 1229.29 L 692 1229.55 L 702 1230.36 L 712 1230.61 L 722 1230.55 L 732 1230.59 L 742 1230.67 L 752 1230.7 L 762 1230 L 762 1230 L 761.75 1238 L 762.24 1246 L 761.85 1254 L 761.82 1262 L 762 1270 L 762 1270.15 L 752 1270.41 L 742 1269.92 L 732 1269.81 L 722 1269.9 L 712 1269.84 L 702 1270.12 L 692 1269.28 L 682 1269.67 L 672 1269.37 L 662 1270 L 661.82 1270 L 662.11 1262 L 662.06 1254 L 661.93 1246 L 661.75 1238 L 662 1230 L 662 1230 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 98px; height: 1px; padding-top: 1250px; margin-left: 663px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">tuberculose = <br />ALD pour 2 ans</div></div></div></foreignObject><text x="712" y="1254" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">tuberculose =...</text></switch></g><rect x="90" y="1930" width="690" height="170" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1937px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div><span>Le dépistage des ITL peut se faire par :</span><br /></div><div><br /></div><div><ul><li>IDR (= intradermoréaction) = RCT (= réaction cutanée tuberculinique) </li><ul><li>interprétation difficile si vaccin BCG &lt; 10 ans car se positive avec M. bovis</li><li>lecture à 72h : IDR positive si induration &gt; 5 mm</li><li>suspicion ITL si <b>&gt; 10 mm sans BCG</b> ou augmentation<b> 10 mm entre 2 IDR en 3 mois</b></li></ul><li>IGRA (détection de production d'<span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">IFN</span><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">-</span><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">γ) par prise de sang</span></li><ul><li><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">VPP meilleure que IDR (osef BCG)</span></li><li><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">résultats après qq jours</span></li></ul></ul></div></div></div></div></foreignObject><text x="97" y="1949" fill="black" font-family="Karla" font-size="12px">Le dépistage des ITL peut se faire par :...</text></switch></g><path d="M 660 2120 L 660 2119.57 L 670 2120.35 L 680 2119.83 L 690 2119.48 L 700 2119.27 L 710 2119.65 L 720 2119.45 L 730 2119.31 L 740 2119.39 L 750 2119.69 L 760 2120 L 759.58 2120 L 759.68 2130 L 759.7 2140 L 759.62 2150 L 760.04 2160 L 760 2170 L 760 2170.53 L 750 2170.57 L 740 2170.68 L 730 2170.3 L 720 2170.02 L 710 2170.54 L 700 2169.96 L 690 2170.54 L 680 2169.64 L 670 2170.28 L 660 2170 L 660.5 2170 L 660.13 2160 L 660.09 2150 L 659.93 2140 L 659.91 2130 L 660 2120 L 660 2120 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 98px; height: 1px; padding-top: 2145px; margin-left: 661px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">toute ITL chez un enfant &lt; 15 doit être déclarée</div></div></div></foreignObject><text x="710" y="2149" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">toute ITL chez u...</text></switch></g><rect x="0" y="1890" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1905px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ITL</div></div></div></foreignObject><text x="30" y="1909" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ITL</text></switch></g><rect x="20" y="1930" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1940px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">dépistage</div></div></div></foreignObject><text x="55" y="1944" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">dépistage</text></switch></g></g><switch><g requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"/><a transform="translate(0,-5)" xlink:href="https://desk.draw.io/support/solutions/articles/16000042487" target="_blank"><text text-anchor="middle" font-size="10px" x="50%" y="100%">Viewer does not support full SVG 1.1</text></a></switch></svg>